Effects of Protein, Lipid, Feeding Levels and Their Interaction ... 71Table 3. The effects of crude protein, crude lipid, feeding rate and their
interaction on blood parameters at the end of 4 months, blood sampled
24 h after feedingParameter TG (mg/dl) CHOL (mg/dl) GLU (mg/dl) TP (g/dl)
CP (P) (%)
L 25533.7 ± 46.6 a 415.1 ± 12.2 a 75.5 ± 1.6 a 3.20 ± 0.14 aH 35 151.1 ± 10.5 b 239.1 ± 9.4 b 66.8 ± 2.2 b 2.35 ± 0.06 b
CL (L) (%)
L 8 275.8 ± 37.0 315.8 ± 20.8 68.8 ± 2.8 2.54 ± 0.10
H 12 366.0 ± 66.0 321.9 ± 26.8 72.3 ± 1.7 2.90 ± 0.16
FR (F) (%)
L 50 222.3 ± 56.5 273.8 ± 33.4 65.8 ± 3.7 b 2.43 ± 0.16
M 70 315.7 ± 46.6 329.2 ± 27.8 69.1 ± 2.2 ab 2.76 ± 0.16
H 100 411.3 ± 86.4 343.0 ± 27.9 76.0 ± 1.7 a 2.95 ± 0.19
Interaction
P x L * ns
P x F ns ns
L x F ns ns ns
P x L x F * ns ns ns
Values are means ± SE; values within the same column without a common superscript
are significantly different (p < 0.05).
TG = plasma triglyceride; CHOL = plasma cholesterol; GLU = plasma glucose; TP =
plasma total protein.
The ranking of the treatments based on the growth performance at the end
of 4 months is shown in Figure 2. Growth response was significantly (P <
0.05) affected by the inclusion level of dietary protein and lipid. The highest
growth was observed in treatment CP35CL8-100% and the lowest was noticed
in treatment CP25CL12-50% which was not significantly different (p > 0.05)
from CP35CL12-50% and CP25CL12-70%.
The ranking of treatments based on the blood parameters at the end of 4
months is shown in Figure 3. Treatments with low crude protein and high or
low crude lipid gained higher plasma TG whereas those with high crude
protein and high or low lipid got lower plasma TG. Similar trend was observed
for blood plasma CHOL. For blood plasma GLU, without treatments
CP25CL6-100% and CP35CL6-50%, there were no significant differences
(p > 0.05) among all the treatments. Blood plasma TP without treatments
CP35CL12-50%and CP35CL6-50% did not have any significant difference
(p > 0.05) among all the treatments.